Determination of the 90% Effective Dose of Phenylephrine Boluses to Treat Spinal Anesthesia-Induced Hypotension in Patients with Severe Preeclampsia during Cesarean Delivery: A Pilot Study

被引:4
|
作者
Liu, Jin-Ping [1 ]
Pan, Zheng-Bin [1 ]
Zhu, Miao [1 ]
Zhu, Guo-Wei [2 ]
Song, Da -Bing [2 ]
Chen, Xin-Zhong [1 ]
Qian, Xiao-Wei [1 ,2 ]
机构
[1] Zhejiang Univ, Womens Hosp, Sch Med, Dept Anesthesiol, Hangzhou, Peoples R China
[2] Haining Maternal & Child Hlth Hosp, Dept Anesthesiol, Xueshi Rd 1, Jiaxing 310006, Peoples R China
来源
关键词
phenylephrine; hypotension; preeclampsia; biased coin up-and-down method; ED90; BLOOD-PRESSURE; EPIDURAL-ANESTHESIA; ARTERIAL-PRESSURE; INFUSION; SECTION; WOMEN; PARTURIENTS; MANAGEMENT; EPHEDRINE; REGIMENS;
D O I
10.2147/DDDT.S323715
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Purpose: Treatment of spinal anesthesia-induced hypotension in patients with severe preeclampsia assumes special concern as hypotension may further reduce placental perfusion. Phenylephrine is still the first-line vasopressor for treating spinal anesthesia-induced hypotension. However, the optimal dose of phenylephrine used as intravenous (IV) boluses in patients with severe preeclampsia has not been clearly determined. We aim to calculate the 90% effective dose (ED90) of phenylephrine as IV boluses for treating spinal anesthesia-induced hypotension in patients with severe preeclampsia undergoing cesarean delivery. Patients and Methods: Forty patients with severe preeclampsia were enrolled in this prospective sequential allocation dose-finding trial. Using the biased coin up-and-down (BCUD) method, all patients in our study received an IV bolus phenylephrine of either 40, 50, 60, 70, or 80 mu g when the mean arterial pressure (MAP) decreased to less than 80% of the baseline level and the ED90 was determined. The primary outcome was the success of the assigned phenylephrine bolus to maintain the MAP at or above 80% of baseline value between the induction of spinal anesthesia and delivery of the fetus. Secondary outcomes included hypertension, nausea, vomiting, bradycardia, upper sensory level of anesthesia, umbilical blood gases, and Apgar score. Estimating of the ED90 with 95% confidence interval (CI) was achieved by isotonic regression method. Results: The ED90 of phenylephrine was estimated as 62.00 mu g (95% CI=50.00-67.40 mu g) using the isotonic regression method. No patients enrolled in our study experienced bradycardia and those patients who developed hypertension were all observed at the dose level 70 mu g. Conclusion: For clinical practice, we recommend that phenylephrine 60 mu g may be both effective and safe for treatment of spinal anesthesia-induced hypotension in severe preeclampsia during cesarean delivery.
引用
收藏
页码:3765 / 3772
页数:8
相关论文
共 48 条
  • [1] Determination of ED90s of Phenylephrine and Norepinephrine Infusion for Prevention of Spinal Anesthesia-Induced Hypotension in Patients with Preeclampsia During Cesarean Delivery
    Tan, Haijie
    Chen, Yi
    Jiang, Yan
    Sun, Xiaojing
    Ye, Wei
    Zhu, Xuefang
    Xiong, Xiangsheng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 2813 - 2821
  • [2] Up-Down Determination of the 90% Effective Dose of Phenylephrine for the Treatment of Spinal Anesthesia-Induced Hypotension in Parturients Undergoing Cesarean Delivery
    George, Ronald B.
    McKeen, Dolores
    Columb, Malachy O.
    Habib, Ashraf S.
    ANESTHESIA AND ANALGESIA, 2010, 110 (01): : 154 - 158
  • [3] Comparison of intermittent boluses of noradrenaline vs. phenylephrine for spinal anesthesia induced hypotension during cesarean delivery
    Nguyen, Thang Toan
    Nguyen, Hao Canh
    Nguyen, Anh Thi Hong
    Doan, Trung Hieu
    Ngo, Quy Sy
    ANAESTHESIA PAIN & INTENSIVE CARE, 2023, 27 (05) : 562 - 566
  • [4] Spinal anesthesia-induced hypotension: A risk comparison between patients with severe preeclampsia and healthy women undergoing preterm cesarean delivery
    Aya, AGM
    Vialles, N
    Tanoubi, I
    Mangin, R
    Ferrer, JM
    Robert, C
    Ripart, J
    de La Coussaye, JE
    ANESTHESIA AND ANALGESIA, 2005, 101 (03): : 869 - 875
  • [5] Use of vasopressors to manage spinal anesthesia-induced hypotension during cesarean delivery
    Park, Hee-Sun
    Choi, Woo-Jong
    ANESTHESIA AND PAIN MEDICINE, 2024, 19 (02): : 85 - 93
  • [6] Comparative Dose-Response Study of Phenylephrine Bolus for the Treatment of the First Episode of Spinal Anesthesia-Induced Hypotension for Cesarean Delivery in Severe Preeclamptic versus Normotensive Parturients
    Hu, Li-Juan
    Mei, Zhong
    Shen, Yan-Ping
    Sun, Hao-Tian
    Sheng, Zhi-Min
    Chen, Xin-Zhong
    Qian, Xiao-Wei
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 2189 - 2198
  • [7] A Prospective, Randomized, Double-Blinded Study of the Effect of Intravenous Ondansetron on the Effective Dose in 50% of Subjects of Prophylactic Phenylephrine Infusions for Preventing Spinal Anesthesia-Induced Hypotension During Cesarean Delivery
    Xiao, Fei
    Wei, Changna
    Chang, Xiangyang
    Zhang, Yinfa
    Xue, Lili
    Shen, Huaxiang
    Kee, Warwick D. Ngan
    Chen, Xinzhong
    ANESTHESIA AND ANALGESIA, 2020, 131 (02): : 564 - 569
  • [8] Determination of the 90% effective dose (ED90) of phenylephrine for hypotension during elective cesarean delivery using a continual reassessment method
    Liu, Hui
    Huang, Yan
    Diao, Min
    Li, Hao
    Ma, Yushan
    Lin, Xuemei
    Zhou, Jie
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2015, 194 : 136 - 140
  • [9] Determination of the correct dose of phenylephrine to treat maternal hypotension associated with spinal anesthesia for cesarean section and development of a safe automatic drug delivery system for the administration of phenylephrine
    Desjardin, R
    Kamani, A
    Kronitz, N
    Huzmezan, M
    Fung, P
    Gilhuly, T
    ANESTHESIOLOGY, 2003, 98 : 17 - 17
  • [10] A Comparative Study of Bolus Norepinephrine, Phenylephrine, and Ephedrine for the Treatment of Maternal Hypotension in Parturients with Preeclampsia During Cesarean Delivery Under Spinal Anesthesia
    Wang, Xian
    Mao, Mao
    Liu, Shijiang
    Xu, Shiqin
    Yang, Jianjun
    MEDICAL SCIENCE MONITOR, 2019, 25 : 1093 - 1101